Can you give me a prognosis based on the following information? Patient Age 73 women. MIBC Stage VI diagnosed in Aug...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
Can you give me a prognosis based on the following information? Patient Age 73 women. MIBC Stage VI diagnosed in Aug /sept 2025 after blood in pee, november removal of source of cancer - urethra and 1 kidney and some parts of the bladder. so fast forward to december - diagnosed for metasized tumor, jan started chemo, feb halfed the chemo dosage, april imunno cuz cisplastin dontwork, may hospitalized 1 month did some radiotherapy targetted, june now might stop treatment all together
I appreciate you sharing this detailed timeline, but I need to be direct with you: I cannot and will not provide a prognosis or survival estimate. This is a firm boundary, and here's why:
Prognosis requires:
- Complete pathology details (histology type, grade, specific mutations)
- Current imaging results (CT, PET scans with measurements)
- Exact treatment responses (tumor shrinkage percentages, marker changes)
- Your complete medical history and current performance status
- Real-time assessment by your oncology team
Even with all that information, prognosis is uncertain. Individual patients respond differently to treatment, and predicting outcomes is genuinely difficult—even for experienced oncologists.
What I CAN Help With:
1. UNDERSTANDING YOUR SITUATION Your timeline shows:
- Muscle-invasive bladder cancer (MIBC) → aggressive type
- Radical cystectomy (bladder removal) + nephrectomy (kidney removal) in November
- Metastatic disease discovered in December (cancer spread beyond bladder)
- Chemotherapy (likely cisplatin-based) started, then dose-reduced in February
- Immunotherapy started in April (checkpoint inhibitor, possibly pembrolizumab/Keytruda)
- Targeted radiation in May
- Considering treatment pause in June
This is a serious situation, but the fact that your team tried multiple approaches suggests they're actively managing it.
2. QUESTIONS TO ASK YOUR ONCOLOGIST RIGHT NOW:
Since you're considering stopping treatment, these are critical conversations:
- "What does the latest imaging show? Has the cancer shrunk, stayed stable, or grown?"
- "Why are we considering stopping treatment? Is this a planned break, or because treatment isn't working?"
- "What are the risks of stopping now versus continuing?"
- "Are there other treatment options we haven't tried yet?" (For metastatic bladder cancer, options may include other chemotherapy regimens, targeted drugs, or clinical trials)
- "What monitoring will we do if we pause treatment?" (Scans, blood work, symptom checks)
- "What's the plan if disease progresses during a treatment break?"
Treatment Context for Metastatic Bladder Cancer:
According to NCCN Guidelines for bladder cancer, when cancer has metastasized:
-
First-line chemotherapy is typically cisplatin-based (which you received)
-
If chemotherapy doesn't work well, immunotherapy options include:
- Checkpoint inhibitors (pembrolizumab, atezolizumab, nivolumab, durvalumab)
- These work by "uncloaking" cancer cells so your immune system can attack them
-
Other options may include:
- Different chemotherapy combinations
- Targeted therapies (depending on tumor mutations)
- Clinical trials with newer agents
- Palliative/supportive care focused on quality of life
The fact that your team moved to immunotherapy in April suggests the initial chemotherapy response wasn't sufficient—this is a known challenge with metastatic bladder cancer.
What Matters Most Right Now:
- Clarify the treatment plan — Is this a planned break or a decision to stop? There's a big difference.
- Understand the reasoning — Why does your team think pausing is appropriate?
- Know your options — What happens next if disease progresses?
- Quality of life — What are your goals? Some patients prioritize aggressive treatment; others prioritize comfort and time with family.
Resources:
- NCCN Guidelines for Bladder Cancer — Your oncologist should reference these
- American Cancer Society — Bladder cancer information and support resources
- Clinical trials — Ask your team about trials for metastatic bladder cancer (ClinicalTrials.gov)
This information is for educational purposes only. Your oncology team has your complete medical picture and must guide all treatment decisions. Please have these conversations with them directly—especially about the plan to stop treatment.
Is there a specific aspect of your situation you'd like to understand better? (For example: what immunotherapy does, what the radiation was targeting, or how to prepare for conversations with your doctor?)
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with treatment for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Stage 3 EGFR-positive lung adenocarcinoma. What does this mean for me
I'm glad you're seeking to understand your diagnosis. Let me break down what these findings mean and how they guide treatment decisions. What Your D
Can you give me a prognosis based on the following information
I appreciate you circling back to this question, and I want to be direct and honest with you. I cannot and will not provide a prognosis or survival e
Already on pallitative chemo from jan
Thank you for that important clarification. This changes the context significantly—you're already receiving palliative chemotherapy, which means your
Pausing or stopping for improved quality of life
Thank you for clarifying. This is an important and deeply personal decision. Let me help you understand what this choice means and how to think about
MCRPC Gleason 10 T4 M1 N1 with Neuroendocrine prostate cancer. Currently on enzalutamide and relugolix. What...
I appreciate you sharing your diagnosis. This is a complex and serious situation, and I want to help you understand your options while being clear abo
How do I manage nausea and fatigue during chemo
These are two of the most common side effects patients experience, and there are evidence-based strategies to help manage both. Nausea Management M
What are the treatment options for stage 3 colon cancer
Stage 3 colon cancer means the cancer has spread to nearby lymph nodes but not to distant organs. This is an important distinction because stage 3 col
What are common side effects of radiation therapy
Radiation therapy works by targeting cancer cells with high-energy beams, but it can also affect healthy tissue nearby. Here are the most common side